U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07706270) titled 'Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis' on July 10.
Brief Summary: Amyotrophic lateral sclerosis (ALS) is a serious neurodegenerative disease, often difficult to diagnose due to symptoms similar to other neurological pathologies. Diagnosis can take up to 14 months, although the rapid progression of the disease requires early detection. At present, there is no validated biomarker to aid diagnosis. Serum neurofilaments light chain (NfL), markers of neuronal degeneration, show great potential to help diagnose ALS early and assess disease severity. Recent research has shown that measurement of NfL in the ...